Valproic Acid [BSA]
Valproic Acid, BSAconjugated
DAG3422 chemosynchetic
Lot. No. (See product label)
PRODUCT INFORMATION
Product overview Valproic Acid, BSAconjugated
Description Valproic Acid, Conjugated
Species chemosynchetic
Source Valproic Acid conjugated with bovine serum albumin (BSA).
Conjugate BSA
Form Liquid; 0.01M PBS,PH7.4
Quality Control Test 1 milligram
PACKAGING
Storage Store at 20°C for one year.
BACKGROUND
Introduction Valproic acid, valproate sodium and divalproex belong to the group of medicines called
anticonvulsants, used to control certain types of seizures in the treatment of epilepsy. Also, valproic
acid relieves histone deacetylases (HDACs) dependent transcriptional repression and causes
hyperacetylation of histones in cultured cells and in vivo. Valproic acid inhibits HDAC activity in vitro,
most probably by binding to the catalytic centre of HDACs. Most importantly, valproic acid induces
differentiation of carcinoma cells, transformed haematopoietic progenitor cells and leukaemic blasts
from acute myeloid leukaemia patients. Moreover, tumour growth and metastasis formation are
significantly reduced in animal experiments. Therefore, valproic acid might serve as an effective drug
for cancer therapy.
Keywords Valproic acid; VPA; Convulex; Depakene; Epilim; Ergenyl; Mylproin; valproate; Valproesαure; Valproic
Creative Diagnostics. All rights reserved
4516 Ramsey Road Shirley, NY 11967, USA
Tel: 6316244882 ·Fax:6316147828
Email: info@creativediagnostics.com
www.creativediagnostics.com